|
|||||
|
|
First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours |
|
| Authors: | Yap T A Cortes-Funes H Shaw H Rodriguez R Olmos D Lal R Fong P C Tan D S Harris D Capdevila J Coronado C Alfaro V Soto-Matos A Fernández-Teruel C Siguero M Tabernero J M Paz-Ares L de Bono J S López-Martin J A |
| Affiliation: | Drug Development Unit, Royal Marsden NHS Foundation Trust, Sutton, UK. |
| Abstract: | |
| Keywords: | cytotoxic novel marine-derived compound phase I PM00104 |
| 本文献已被 PubMed 等数据库收录！ | |